shutterstock_1569359980_sundry_photography
Sundry Photography / Shutterstock.com
21 February 2020AmericasRory O'Neill

Gilead fails to have US government patents invalidated

Gilead Sciences has failed in its efforts to have US government patents covering the use of HIV drugs as pre-exposure prophylaxis (PrEP) invalidated.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
22 August 2019   Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.
Americas
2 March 2020   Gilead Sciences has agreed a $4.9 billion deal to buy California-based immuno-oncology company Forty Seven.
Americas
19 May 2020   The US government has urged a Delaware federal court to throw out patent infringement claims from Gilead Sciences over HIV prevention medicines.

More on this story

Americas
22 August 2019   Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.
Americas
2 March 2020   Gilead Sciences has agreed a $4.9 billion deal to buy California-based immuno-oncology company Forty Seven.
Americas
19 May 2020   The US government has urged a Delaware federal court to throw out patent infringement claims from Gilead Sciences over HIV prevention medicines.

More on this story

Americas
22 August 2019   Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug.
Americas
2 March 2020   Gilead Sciences has agreed a $4.9 billion deal to buy California-based immuno-oncology company Forty Seven.
Americas
19 May 2020   The US government has urged a Delaware federal court to throw out patent infringement claims from Gilead Sciences over HIV prevention medicines.